The Journal of Antibiotics (2026) 79:542–553 https://doi.org/10.1038/s41429-026-00935-x ARTICLE Inhibition of the SOS response by olivetol improves the efficacy of DNA-damaging antibiotics in Escherichia coli Beste Şener1 Barış Gökalsın ● 2 1234567890();,: 1234567890();,: Received: 6 February 2026 / Revised: 17 April 2026 / Accepted: 24 May 2026 / Published online: 4 June 2026 © The Author(s) 2026. This article is published with open access Abstract It is known that the rapid increase in antibiotic-resistant bacteria is reducing the effectiveness of existing antibiotics. The spread of resistant Escherichia coli strains has become a major concern in public health. Developing compounds that increase antibiotic activity is a promising alternative strategy to overcome this problem. SOS response mechanism in bacteria activates DNA repair and increases antibiotic resistance. Natural sources, such as lichens, are valuable for discovering potential SOS inhibitors due to their unique secondary metabolites with medicinal potential. This study aims to enhance the efficacy of antibiotics in E. coli by inhibiting SOS with olivetol, a natural metabolite derived from lichens. The SOS inhibition potential of olivetol was quantitatively assessed using qRT-PCR and GFP-based monitor strains. Moreover, MIC values of DNA damage-inducing ciprofloxacin, trimethoprim, nitrofurantoin and mitomycin C antibiotics were reassessed following combined treatment with olivetol. Overall, the results show that olivetol effectively suppresses the SOS response at high concentrations and reduces the MIC values of the antibiotics trimethoprim, nitrofurantoin, and mitomycin C. These findings indicate that olivetol has significant potential as a natural SOS inhibitor that can enhance the performances of certain antibiotics. Introduction The therapeutic use of antibiotics to treat bacterial infections is becoming increasingly limited due to the rise in antibiotic resistance among bacteria. The detection of resistance to all antibiotics in clinical use poses a serious threat to global public health [1]. Moreover, it is known that at least 700,000 people die every year due to infections resistant to antimicrobial drugs. It is projected that this number could reach 10 million by 2050 and could be the main cause of death worldwide [2]. The treatment of Escherichia coli infections, which affect hundreds of millions of people each year, is threatened by the spread of resistant E. coli strains [3]. Pathogenic E. coli strains such as O157:H7 can cause * Barış Gökalsın baris.gokalsin@marmara.edu.tr 1 Biology Department, Marmara University, Institute of Pure and Applied Sciences, Istanbul, Turkey 2 Department of Biology, Marmara University, Faculty of Science, Istanbul, Turkey serious illnesses such as severe hemorrhagic colitis, diarrhea, and hemolytic uremic syndrome by producing Shiga toxin [4]. Moreover, in the United States, more than 265,000 foodborne illness cases associated with Shiga toxin-producing E. coli (STEC) occur each year, resulting in 3600 hospitalizations and 30 deaths [5]. According to a report released by the European Centre for Disease Prevention and Control (ECDC) in 2019, 44% of bacterial infection cases identified in Europe were attributed to E. coli, and more than half of these cases were reported to be resistant to at least one antibiotic [6]. Therefore, there is a need to develop new alternative strategies to combat bacterial infections. One such strategy involves compounds that reduce resistance mechanisms without killing bacteria. For example, quorum sensing (QS) is a bacterial communication system that regulates virulence, biofilm formation, and resistance without inhibiting bacterial growth. QS inhibitors such as allicin [7], aloin, and emodin [8] block the QS system through various mechanisms, including inhibition of autoinducer synthesis, signal receptor antagonism, enzymatic degradation (quorum quenching), or suppression of gene expression regulated by QS [9]. Meanwhile, efflux mechanisms are considered a critical factor in the development of resistance Inhibition of the SOS response by olivetol improves the efficacy of DNA-damaging antibiotics in. . . 543 Fig. 1 Activation of the SOS pathway to many antibiotics because they increase intracellular antibiotic concentrations by inhibiting the activity of membrane transporters responsible for the efflux of antibiotics in bacteria. Compounds such as reserpine [10], berberine [11], and piperine [12] inhibit efflux mechanisms, thereby restoring microbial susceptibility to antibiotics or reducing the opportunity for resistant mutants to be selected [13]. Another promising approach for reducing antibiotic resistance is the SOS response. Targets for inhibiting the SOS pathway include preventing the activation of the regulon by inhibiting RecA filamentation and blocking LexA autoproteolysis [14]. Compounds that possess SOSinhibiting properties include suramin [15], zinc acetate [16]. In this context, one target has emerged: to enhance the efficacy of antibiotics that cause DNA damage by inhibiting the SOS response, which induced by these antibiotics and contributes to bacterial survival, mutagenesis and adaptive resistance, thereby reducing the development of antibiotic resistance. Originally known only to regulate DNA damage repair, the SOS response is a global stress response activated in both susceptible and resistant bacteria upon DNA damage and plays a role in physiological processes that enable bacteria to develop resistance to antibiotics [17, 18]. Antibiotics that cause DNA damage induce the SOS response, leading to detoxification of reactive oxygen species (ROS), horizontal gene transfer (HGT), biofilm formation, persister cell formation, hypermutation states, and the formation of small colony variants (SCVs) [19]. Therefore, inhibition of the SOS response has emerged as a rational adjuvant strategy. It has also reported that adaptive resistance mutations induced by antibiotic treatment and the acquisition of resistance genes are also due to the activation of the SOS system [20]. Bacteria exposed to various stresses, including antimicrobials that cause DNA damage, induce the expression of a set of genes known as the SOS response (Fig. 1). These genes are mainly regulated by two key proteins: LexA protein suppresses the response in the absence of DNA damage, whereas RecA protein activates the SOS system to express target genes when DNA damage occurs [21]. When DNA damage occurs, RecA binds to singlestranded DNA (ssDNA) forming an ssDNA-RecA complex (active RecA). It then triggers the autoproteolysis of LexA, inactivating it and inducing the expression of over 50 SOSassociated genes. These genes include dinI, a DNA damageinducible protein that stabilizes RecA filaments, sulA, an inhibitor of cell division, dinB and umuDC, which encode lowquality and error-prone DNA polymerases with diverse functions such as DNA repair and mutagenesis [22]. Inhibition of the SOS response has become a target as a potential and promising treatment method to increase the sensitivity of existing antibacterial agents used today for bacterial infections. Bellio et al. (2017) demonstrated that certain secondary metabolites, such as lichesterinic, divaricatic, epiphorellic acids, tumidulin and sphaerophorin, inhibit the ATP-hydrolytic activity of RecA [23]. In addition, previous studies have shown that deletion of the recA gene restores sensitivity to ciprofloxacin in resistant E. coli strains [24] and that phthalocyanine tetrasulfonate (PcTs)based chemical RecA inhibitors enhance the efficacy of antibiotic classes such as quinolones, β-lactams, and aminoglycosides by blocking the SOS response [25]. At this stage, the need to identify natural resources that can inhibit the SOS response emerges. With more than 20,000 species and covering 8% of the Earth’s surface, lichens have been used in the treatment of diseases for a long time [26]. Lichens have the unique ability to naturally synthesize many secondary metabolites in response to environmental stress. Among these metabolites, wellcharacterized compounds such as usnic acid, atranorin, fumaprotoketaric acid, and depsidones have been extensively studied and demonstrated for their various biological effects [26, 27]. The potential medical applications of secondary metabolites with varying functions and properties have motivated numerous researchers to investigate this subject. These metabolites, which have various biological activities such as antibacterial [28], antiviral [29], antifungal B. Şener, B. Gökalsın 544 [30], antitumor [31] and anti-QS [32], have attracted considerable attention in antimicrobial research. Taken together, these metabolites may be promising candidates for the discovery of natural SOS inhibitors. Olivetol, also known as 5-pentylresorcinol, is a naturally occurring metabolite found in lichens and is classified as a resorcinolic phenol. Additionally, olivetol is a precursor molecule for tetrahydrocannabinol (THC) and cannabidiol (CBD) in the biosynthesis of cannabinoids, particularly in the plant species Cannabis sativa. [33]. Olivetol is a naturally occurring metabolite found in several lichen species. It has been detected in Cetrelia monachorum and Lepraria incana [34], whose extracts show anti-inflammatory activity. It is also present in Hypogymnia tubulosa and Hypogymnia physodes, which exhibit antimicrobial and antifungal activities [26, 35]. In addition, Taslimi and Gulçin (2018) revealed in their study that olivetol has antioxidant and anticholinergic properties. Olivetol’s diverse biological activities, small molecular composition and affordability indicate that it could be a promising compound for targeting the SOS response [33]. This study aims to investigate the potential of olivetol, a lichen-derived secondary metabolite, as an inhibitor of the SOS response in E. coli. Although olivetol is known for various biological activities, its effect on the bacterial SOS response has not yet been explored. It is hypothesized that olivetol suppresses SOS activation and thereby enhances the efficacy of DNA-damaging antibiotics. This approach targets antibiotics that inhibit DNA replication and integrity, including ciprofloxacin (DNA gyrase and topoisomerase IV inhibitor), trimethoprim (indirectly suppresses DNA synthesis by affecting folate synthesis), nitrofurantoin (causing DNA damage by forming reactive intermediates) and mitomycin C (forming DNA cross-linking) [36]. To evaluate this potential, SOS green fluorescent protein (GFP) reporter assays were performed using recA-gfp and PsulA-gfp biomonitor strains. Subsequently, the minimum inhibitory concentration (MIC) values of the relevant antibiotics were determined. Effective olivetol concentrations identified in the reporter assays were then combined with antibiotics at sub-MIC levels to assess their effects on MIC values. Finally, qRT-PCR analysis was conducted to examine changes in the expression of the SOS-related genes recA, sulA, and lexA. Together, these approaches provide a comprehensive evaluation of whether olivetol can enhance antibiotic efficacy by targeting the SOS response. Materials and methods Bacterial strains E. coli strains used in this study included E. coli recA-gfp (Pwt-recA-gfp; recA-gfp fusion with wild-type RecA promoter) and PsulA-gfp (Wild type promoter) biomonitor strains were used to detect SOS inhibition. These monitor strains were kindly provided by Andrew Robinson and Antoine van Oijen from University of Wollongong [37, 38]. E. coli O157:H7 strain was used for antimicrobial tests and qRT-PCR analyses. Bacteria were normally grown in Tryptic Soy Broth (TSB), and Mueller-Hinton Broth (MHB) media were used for antimicrobial tests. For GFP expression assays, M9 minimal media supplemented with MgSO4 (2 mM), CaCl2 (0.1 mM), thiamine (2.5 mg/l), glucose [0.5% (wt/vol)], and casamino acids [0.5% (wt/ vol)] was used. Kanamycin (25 µg/ml) was added to MHB and M9 media for biomonitor strains. SOS GFP reporter assay A modified method of Henrikus et al. (2020) was utilized for GFP expression assays [39]. GFP fluorescence measurements were performed in 96-well black microplates containing M9 growth medium. These media contained ciproloxacin with a final concentration of 0.002 µg/ml, which is necessary for SOS activation. recA-gfp and PsulAgfp biomonitor strains were treated with olivetol ( ≥ 98% purity; Sigma-Aldrich, St. Louis, MO, USA), which was dissolved in dimethyl sulfoxide (DMSO), at final concentrations of 400 μM and 800 μM, respectively, to reach a total culture volume of 200 μl with an OD600 of 0.1. To allow for a clearer monitoring of the time dependent changes in GFP fluorescence, the plates were incubated at 36 °C to slightly slow bacterial growth and plates were monitored every 15 minutes for 16 h using a multimode microplate reader (Biotek, USA). To minimize potential absorbance interference that could arise from intrinsic color of olivetol during GFP expression measurements, bacterial growth and was measured at OD450 nm; fluorescence measurements were performed at λexcitation = 485 nm, λemission = 535 nm wavelengths. Inhibition percentages for the applied olivetol concentrations were calculated at the end of 16 hours. Minimum inhibitory concentration (MIC) assays MIC values of ciprofloxacin, trimethoprim, nitrofurantoin and mitomycin C antibiotics were determined using broth microdilution method in accordance with CLSI guidelines (CLSI M07-A11). MHB medium was added to each well in 96-well plates and serial dilutions of the antibiotics were performed. E. coli O157:H7 and ATCC 25922 suspension was then added to obtain a final OD600 of 0.01, and plates were incubated at 37 °C with shaking. Bacterial growth was determined by absorbance measurements at OD450 nm, to minimize any potential absorbance interference caused by the characteristic color of the antibiotics, after 20 h using Cytation 3 multimode microplate reader. MIC values were Inhibition of the SOS response by olivetol improves the efficacy of DNA-damaging antibiotics in. . . Table 1 Primers used in qRT-PCR for E. coli Primer recA sulA lexA 16S Sequence (5′ → 3′) Reference Forward AGATCCTCTACGGCGAAGGT [48] Reverse CCTGCTTTCTCGATCAGCTT [48] Forward GCCGGGCTTATTCAGTGAAGT [49] Reverse CCTGAACCCATTCCCGACTC [49] Direction Forward GACTTGCTGGCAGTGCATAA [48] Reverse CGTAAGGGCCATGATGACTT [48] Forward CAGCTCGTGTCGTGAGATGT [50] Reverse CGTAAGGGCCATGATGACTT [50] recorded as the lowest antibiotic concentration at which no visible growth was observed, and for OD values showed ≥90% inhibition compared to the untreated control. Additionally, to clarify MIC values and distinguish them from the minimum bactericidal concentration (MBC), 10 µl of suspension taken from clear wells was spread onto Mueller–Hinton Agar (MHA) medium, and the plates were incubated at 37 °C for 24 h. Concentrations at which colony formation was observed on the agar surface were recorded as MIC, while concentrations at which no colonies were observed were recorded as MBC. Determination of antibacterial properties of olivetol The antibacterial activities of 800 and 400 µM olivetol concentrations of secondary metabolite on O157:H7 and ATCC 25922 E. coli strains were determined. The experiments were carried out according to the method described in MIC methods using 96-well transparent microplates. After incubation at 37 °C with shaking at 160 rpm for 20 h, OD450 nm was measured using a Cytation 3 multimode microplate reader to assess the effect of olivetol on bacterial growth. Combination treatment assays Experiments were performed according to a modified method of that described by Revitt-Mills et al. [38]. Olivetol at 800 μM and 400 μM concentrations were treated with ½×, ¼× and ⅛× MIC (sub-MIC1, sub-MIC2, sub-MIC3) of ciprofloxacin, trimethoprim nitrofurantoin and mitomycin C antibiotics to determine their combined antimicrobial activities. Experiments were conducted at 37 °C in MHB medium with shaking using E. coli O157:H7 and ATCC 25922 strains in 96-well transparent microplates. The final bacterial concentration was adjusted to an OD600 of 0.01, and changes in antibiotic MIC values were determined by comparing OD450 measurements after 20 h. New MIC values were defined as the lowest antibiotic concentration that completely inhibited visible bacterial growth and reduced optical density by at least 90% compared to the 545 untreated control, as described in MIC assays. The suspension from the wells where no reproduction was observed was inoculated into MHA medium and MBC values were determined. Gene expression analyses Gene expression analyses were performed according to a modified method of that described by Gökalsın et al. [40]. Overnight cultures of E. coli O157:H7 strain were treated with the 800 and 400 μM concentrations of olivetol. Additionally, ciprofloxacin was used to activate the SOS system at a final concentration of 0.002 µg/ml. Cultures were incubated at 37 °C until late log phase. After incubation, pellets were retrieved and bacterial RNA extraction was performed using Roche High Pure RNA Isolation Kit (Roche) along with random and oligo dT primers (kit components). Purities and concentrations of RNA samples were measured using Cytation 3 with Take3 plate (Biotek). cDNA synthesis of RNA samples whose concentrations were equalized was performed with Transcriptor First Strand cDNA Synthesis Kit (Roche). FastStart Essential DNA Green Master Kit (Roche) was used to measure the level of SOS genes, including recA, sulA and lexA. The primer sequences are listed in Table 1. Finally, the qRT-PCR findings were analyzed by Pfaffl method [41] and 16S gene was used as control for normalization. Expression levels were compared to the control group containing 1% DMSO. Statistical analyses All experiments were carried out in triplicate. The statistical analyses were performed using GraphPad V 9.0 Prism statistics software. Data are presented as means; error margins are presented as standard deviation (SD). Statistical significance was determined using the Kruskal- Wallis test followed by Dunn’s multiple comparison test. For qRTPCR analyses, statistical significance was assessed using the Mann–Whitney U test. p values below 0.05 were considered statistically significant. In the graphs, ns is shown as nonsignificant, *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001. Results Dose-dependent inhibitory effect of olivetol against E. coli SOS response The results, shown in Fig. 2, are the means of three replicates of GFP expressions. The results for the recA-gfp and PsulA-gfp strains are presented as relative 546 B. Şener, B. Gökalsın Fig. 2 Dose–response curves showing the effects of olivetol treatment at 800 and 400 μM on recA-gfp (A) and PsulA-gfp (B) reporter strains. Data are presented as relative fluorescence units (RFU). No growth inhibition was observed at optical densities above 450 nm Inhibition of the SOS response by olivetol improves the efficacy of DNA-damaging antibiotics in. . . 547 Fig. 3 Percentage growth of Escherichia coli O157:H7 (A) and ATCC 25922 (B) strains following treatment with olivetol. Bacterial growth was monitored at OD₄₅₀ using a microplate reader. Growth was normalized to the untreated control and expressed as percentage growth inhibition. Olivetol at 800 μM showed a moderate inhibitory effect, whereas 400 μM had a minimal effect on cell growth. Data are presented as mean ± standard deviation (SD), statistical comparisons were performed relative to the untreated control fluorescence units (RFU) since olivetol treatment did not cause any growth inhibition on the reporter strains. SOS response inhibitions by olivetol were evaluated by comparison to untreated controls. Inhibition values were calculated based on RFU values measured after 16 h. The results indicate that olivetol suppresses GFP expression associated with recA-gfp and PsulA-gfp, achieving approximately 42.77 ± 2.03% and 43.85 ± 0.99% inhibition, respectively, at a concentration of 800 µM. 400 μM olivetol exhibited inhibition rates of 27.20 ± 2.04% for recA-gfp and 34.23 ± 2.15% for PsulA-gfp. MIC values of antibiotics The ability of ciprofloxacin, nitrofurantoin, trimethoprim, and mitomycin C to cause DNA damage and thereby activate SOS system is widely known. Therefore, these antibiotics were selected to inhibit SOS response system with olivetol and thus reduce MIC values. In line with this objective, their MIC and sub-MIC values were determined using broth microdilution method for E. coli O157:H7 and ATCC 25922 strain. After incubation, untreated controls showed normal bacterial growth, while increasing antibiotic concentrations resulted in decreased turbidity and OD450 values. Ciprofloxacin exhibited the lowest MIC value (0.016 µg/ml) against both strains, whereas nitrofurantoin showed the highest MIC value at 14 µg/ml. Trimethoprim and mitomycin C MIC values of 0.25 µg/ml and 0.5 µg/ml, respectively. Subsequently, sub-MIC concentrations (½×, ¼×, and ⅛× MIC) were selected for olivetol treatment. Antibacterial properties of olivetol Olivetol secondary metabolite concentrations of 800 and 400 µM were applied to O157:H7 and ATCC 25922 strains and their antibacterial activities were tested. The results were analyzed by calculating the % inhibition values of bacterial growth at OD450 compared to the untreated control group. Growth % bars are presented in Fig. 3. Treatment with 800 µM olivetol against O157:H7 strain resulted in a 49.72 ± 4.13% inhibition in bacterial growth (p < 0.05). 400 µM olivetol showed no statistically significant difference, with an inhibition rate of 18.35 ± 2.60%. For the ATCC 25922 strain, 800 µM olivetol reduced bacterial growth by 63.68 ± 3.25%, while 400 µM olivetol increased bacterial growth by −7.37 ± 7.04%. Assessment of olivetol-induced potentiation of antibiotic activity The DNA-damaging antibiotics ciprofloxacin, trimethoprim, nitrofurantoin and mitomycin-c were used in combination with olivetol. The results are shown in Figs. 4 and 5, and changes in MIC values are shown in Table 2. According to the results, olivetol at a concentration of 800 µM showed significant effects on trimethoprim, nitrofurantoin and mitomycin C in the O157:H7 strain. 800 µM olivetol concentration successfully halved the MIC of nitrofurantoin (p < 0.01) while reducing the MIC of mitomycin C by 8-fold (p < 0.0001). On the other hand, the combination of 800 µM olivetol + sub-MIC1 trimethoprim exhibited bactericidal activity. Furthermore, an olivetol B. Şener, B. Gökalsın 548 Fig. 4 Inhibition percentages of olivetol–antibiotic combinations against E. coli O157:H7. The antibiotics used were A: ciprofloxacin (Cipro), B: trimethoprim (Trimeth), C: nitrofurantoin (Nitro), and D: mitomycin C (Mito C). Bacterial growth at OD₄₅₀ was analyzed and expressed as percentage inhibition. Bars represent growth under three sub-MIC antibiotic levels (sub-MIC1 = ½×MIC, sub-MIC2 = ¼×MIC, sub-MIC3 = ⅛×MIC), with or without olivetol. Untreated and antibiotic-only sub-MIC groups were included as controls. Growth in the presence of 400 or 800 μM olivetol is shown relative to antibiotic treatment alone. Data are presented as mean ± standard deviation (SD), statistical comparisons were performed relative to the untreated control concentration of 400 µM was sufficient to reduce the mitomycin C MIC value of the O157:H7 strain by a factor of 2 (p < 0.01). However, our tests showed that the ciprofloxacin MIC value remained unchanged in the presence of any olivetol concentration for O157:H7 strain. However, in the ATCC 25922 strain, 800 µM olivetol reduced the MIC of ciprofloxacin 2-fold (p < 0.01). Similarly, it halved the MIC of nitrofurantoin (p < 0.01) and showed the most pronounced effect against mitomycin C. While 400 µM olivetol reduced the mitomycin C MIC value 2-fold (p < 0.001), 800 µM resulted in a 4-fold reduction (p < 0.01). Additionally, although no change was observed in the MIC of trimethoprim, the combination of 800 µM olivetol and sub-MIC₁ trimethoprim reduced bacterial growth by 76.89 ± 2.71% (p < 0.01). method, taking into consideration PCR efficiency and shown in Fig. 6. The results show that 800 μM olivetol substantially suppressed the expression levels of the recA, sulA and lexA genes by 83.24 ± 5.97%, 83.11 ± 5.59% and 57.28 ± 2.34, respectively. In contrast, treatment with 400 μM olivetol did not cause a statistically significant difference in recA and sulA expression compared to the control group, although it caused an upregulation in lexA expression. These findings indicate that olivetol can significantly suppress the SOS response in E. coli O157:H7, particularly at high concentrations. Olivetol downregulates the expression of SOS response-associated genes (recA, sulA, lexA) The expression levels of the recA, lexA and sulA genes were relatively quantified. Cq values were analyzed using Pfaffl Discussion In the near future, it is predicted that current antibiotics will become ineffective against increasing levels of bacterial resistance, and classic bacterial infections will re-emerge as major causes of mortality [1]. In particular, the spread of resistant strains of E. coli, which is the cause of common bacterial infections, has become a serious public problem. Inhibition of the SOS response by olivetol improves the efficacy of DNA-damaging antibiotics in. . . 549 Fig. 5 Inhibition percentages of olivetol–antibiotic combinations against E. coli ATCC 25922. The antibiotics used were A: ciprofloxacin (Cipro), B: trimethoprim (Trimeth), C: nitrofurantoin (Nitro), and D: mitomycin C (Mito C). Bacterial growth at OD₄₅₀ was analyzed and expressed as percentage inhibition. Bars represent growth under three sub-MIC antibiotic levels (sub-MIC1 = ½×MIC, sub-MIC2 = ¼×MIC, sub-MIC3 = ⅛×MIC), with or without olivetol. Untreated and antibiotic-only sub-MIC groups were included as controls. Growth in the presence of 400 or 800 μM olivetol is shown relative to antibiotic treatment alone. Data are presented as mean ± standard deviation (SD), statistical comparisons were performed relative to the untreated control Accordingly, it is important to develop therapeutic interventions and alternative strategies to prevent and control these infections. Therefore, effective management of antibiotic resistance requires the development of compounds that either serve as alternatives to conventional antibiotics or enhance the efficacy of existing antibiotic therapies. In this context, the need for a better understanding of the relevant bacterial physiological pathways has become apparent. Particularly, SOS pathway functions in response to DNA damage and initiates various pro- survival and resistance mechanisms such as DNA repair, hypermutation and HGT. detoxification of ROS, biofilm formation, dissemination of virulence factors, and the production of SCVs. This may represent the SOS response a potential target for combating drug-resistant pathogens [42]. In this context, suppression of the SOS response is considered an important target for enhancing the efficacy of antibiotics and providing an effective strategy against antibiotic resistance [43]. However, despite the growing interest in targeting this pathway, the SOS inhibitory potential of many natural compounds, particularly lichen-derived secondary metabolites, remains largely unexplored. The present study demonstrates that the lichen metabolite olivetol inhibits the E. coli SOS response and enhances the efficacy of various antibiotics when used in combination. According to reporter assay results, olivetol at 800 μM was significantly more effective than at 400 μM in inhibiting recA and sulA expressions. recA-gfp monitor strain was used because RecA functions as the activator of the SOS mechanism, whereas the PsulA-gfp monitor strain was utilized since sulA is directly regulated by the SOS response. The inhibition observed in recA and sulA in the GFP expression assays was consistent with the qRT-PCR results, which confirmed that 800 μM olivetol downregulated recA and sulA by approximately 6-fold. These findings align with the known role of RecA in mediating DNA damage induced LexA autoproteolysis. By suppressing recA expression, olivetol is likely to stabilize LexA, thereby reducing the transcription of genes regulated by SOS [44]. The marked decrease in sulA expression, a gene directly regulated by LexA, supports the effective suppression SOS system [45]. The reduction in lexA mRNA B. Şener, B. Gökalsın 550 Table 2 Changes in MIC values (µg/ml) in E. coli O157:H7 and ATCC 25922 strains in the presence of olivetol MIC (µg/ml) O157:H7 ATCC 25922 Ciprofloxacin Trimethoprim Nitrofurantoin Mitomycin C 800 µM Olivetol 0.016 0.0625 (**) 7 (**) 0.0625 (**) 400 µM Olivetol 0.016 0.25 14 0.125 (****) 0 µM Olivetol 0.016 0.25 14 0.5 800 µM Olivetol 0.008 (**) 0.25 7 (**) 0.0125 (*) 400 µM Olivetol 0.016 0.25 14 0.25 (***) 0 µM Olivetol 0.016 0.25 14 0.5 Bold values indicate changes in MIC compared with the corresponding untreated control (0 µM olivetol) Asterisks indicate the level of statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Fig. 6 Relative expression levels of recA (A), sulA (B), and lexA (C) genes in E. coli O157:H7treated with 400 or 800 μM olivetol. Gene expression levels were normalized to 16S rRNA and compared with the 1% DMSO control group is interpreted as olivetol increasing the stability of the LexA protein and downregulating gene expression through negative feedback. As long as the LexA protein is stable, the cell is thought to limit LexA production. Alternatively, it could be proposed that olivetol acts on another mechanism regulating lexA transcription [46]. Overall, the coordinated downregulation of recA, sulA, and lexA in the presence of 800 μM olivetol demonstrates that olivetol effectively suppresses activation of the SOS response. This finding agrees with previous studies showing that inhibition or silencing of recA suppresses SOS induction. Bellio et al. screened 27 lichen-derived secondary metabolites and identified nine compounds with over 80% RecA inhibition, highlighting lichens as a rich source of natural SOS inhibitors [23]. Since activation of the SOS system contributes directly to adaptive resistance, mutagenesis, and antibiotic treatment failure, targeting this pathway represents an effective strategy for improving antimicrobial activity [25, 43]. Results for the E. coli O157:H7 and ATCC 25922 strains demonstrated that olivetol molecule can reduce bacterial growth when used in combination with antibiotics that cause DNA damage. Consistent with gene expression and GFP reporter data, an olivetol concentration of 800 µM was more effective in reducing antibiotic MIC values for O157:H7 strain. Among the tested antibiotics, mitomycin C exhibited the most pronounced efficacy against both E. coli O157:H7 and ATCC 25922 strains. MIC of mitomycin C for O157:H7 decreased 8-fold in the presence of 800 µM olivetol, whereas for ATCC 25922, it decreased 4-fold. Notably, even at a lower concentration (400 µM), olivetol reduced the MIC of mitomycin C by 2-fold for both strains. These findings are consistent with previous reports showing that disruption of the SOS response significantly increases mitomycin C activity. Mo et al. (2016) reported a 16-fold reduction in the MIC of mitomycin C in a ΔrecA strain, suggesting that the complete elimination of recA leads to a stronger senitization effect than chemical inhibition alone [43]. In the case of trimethoprim for O157:H7 strain, a bactericidal effect was exhibited by 800 µM olivetol when combined with ¼×MIC of trimethoprim, further supporting the role of SOS suppression in enhancing antibiotic efficacy. In addition, while 800 µM olivetol successfully reduced the MIC of trimethoprim by 2-fold, no change in the MIC value was observed in the ATCC 25922 strain. Similarly, a previous study demonstrated that recA inactivation reduced the MIC values of trimethoprim and, alongside it, ceftazidime, fosfomycin, and colistin in E. coli, and limited the emergence of resistant mutants by blocking the SOS response [47]. Inhibition of the SOS response by olivetol improves the efficacy of DNA-damaging antibiotics in. . . For nitrofurantoin, treatment with 800 µM olivetol resulted in a 2-fold reduction in MIC values for both E. coli strains. In line with this observation, Mo et al. (2016) reported a ≥4-fold decrease in nitrofurantoin MIC ΔrecA strains, further supporting the contribution of SOS inhibition to increased antibiotic susceptibility [43]. Conversely, the impact of olivetol on ciprofloxacin activity in the O157:H7 strain was not statistically significant, and no reduction in MIC values was observed. However, in the ATCC 25922 strain, the MIC value of ciprofloxacin was reduced by half in the presence of 800 µM olivetol. Previous studies have demonstrated that recA deletion can restore sensitivity to ciprofloxacin in resistant E. coli strains [24] and that chemical recA inhibitors enhance the activity of quinolones, β-lactams, and aminoglycosides by blocking the SOS response [25]. In contrast, the absence of any statistically significant effect observed in O157:H7 strain may reflect strain-specific differences, partial SOS inhibition, or fundamental differences between genetic deletion and chemical modulation of the recA gene. It is thought that the more pronounced reductions in MIC values reported in studies employing recA deletion are due to the complete elimination or silencing of the recA gene. Collectively, these findings indicate that chemical suppression of the SOS response by olivetol partially mimics the effects of recA inactivation, thereby preventing RecA filamentation and leading to enhanced susceptibility to DNA damage-inducing antibiotics, although the magnitude of this effect varies depending on the antibiotic and bacterial strain. Although SOS activation has been linked to biofilm formation, toxin production, and virulence regulation [42]; this study focused on the effects of olivetol on the SOS response and antibiotic susceptibility. Furthermore, the significant growth inhibition observed in combination therapies limits the evaluation of features associated with biofilm formation or virulence. To investigate these effects in detail, future studies conducted at lower sub-MIC levels would be valuable. Nevertheless, several limitations should be considered. The potential of olivetol to reverse existing resistance could not be directly assessed. Although SOS inhibition is associated with reduced mutagenesis and resistance development, this study did not include long-term evolutionary analyses to evaluate olivetol’s effect on the emergence of resistance. To fully assess olivetol’s translational potential as an antimicrobial adjuvant, future studies incorporating in vivo evaluation, toxicological profiling, and long-term evolutionary analyses are required. This study demonstrates that olivetol, at higher concentrations, can suppress the expression of SOS associated genes, leading to enhanced susceptibility of E. coli to DNA damage- 551 inducing antibiotics, including ciprofloxacin, trimethoprim, nitrofurantoin, and mitomycin C. These findings highlight the potential of natural compound-based SOS inhibitors to improve antibiotic efficacy and limit antimicrobial resistance. Author contributions Barış Gökalsın: Conceptualization, study design, supervision, data interpretation, funding acquisition, and manuscript writing and revision. Beste Şener: Experimental work, data acquisition, formal analysis, visualization, and drafting of the original manuscript. Funding This work was supported by Marmara University Scientific Research Projects Unit with project number FYL-2023-10968. Open access funding provided by the Scientific and Technological Research Council of Türkiye (TÜBİTAK). Compliance with ethical standards Conflict of interest The authors declare no competing interests. Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons. org/licenses/by/4.0/. References 1. Bush K, et al. Tackling antibiotic resistance. Nat Rev Microbiol. 2011;9:894–6. https://doi.org/10.1038/nrmicro2693. 2. O’Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. London: Review on Antimicrobial Resistance; 2014. 3. Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010;8:26–38. https://doi. org/10.1038/nrmicro2265. 4. Xu J, et al. Available phosphorus and opportunistic pathogens drive geographic variation in Escherichia coli O157: H7 survival in soils across eastern China. Nat Food. 2025;6:777–86. https:// doi.org/10.1038/s43016-025-01191-2. 5. Scallan E, et al. Foodborne illness acquired in the United Statesmajor pathogens. Emerg Infect Dis. 2011;17:7 https://doi.org/10. 3201/eid1701.p11101. 6. European Centre for Disease Prevention and Control. Annual Epidemiological Report for 2020. Stockholm; 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/ AER-EARS-Net-2020.pdf (accessed 6 Mar 2024). 7. Chadha J, Harjai K, Chhibber S. Repurposing phytochemicals as anti-virulent agents to attenuate quorum sensing-regulated virulence factors and biofilm formation in Pseudomonas aeruginosa. 552 Microb Biotechnol. 2022;15:1695–718. https://doi.org/10.1111/ 1751-7915.13981. 8. Jiang L, et al. Aloe-emodin Attenuates Staphylococcus aureus Pathogenicity by Interfering with the Oligomerization of α-Toxin. Front Cell Infect Microbiol. 2019;9:157 https://doi.org/10.3389/ fcimb.2019.00157. 9. Alum EU, et al. Natural product-based inhibitors of quorum sensing: A novel approach to combat antibiotic resistance. Biochem Biophys Rep. 2025;43:102111 https://doi.org/10.1016/j. bbrep.2025.102111. 10. Stavri M, et al. Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother. 2007;59:1247–60. https://doi. org/10.1093/jac/dkl460. 11. Giorgini G, et al. Berberine derivatives as Pseudomonas aeruginosa MexXY-OprM inhibitors: activity and in silico insights. Molecules. 2021;26:6644 https://doi.org/10.3390/molecules26216644. 12. Sharma S, et al. Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis. J Antimicrob Chemother. 2010;65:1694–701. https://doi.org/10.1093/ja c/dkq186. 13. Zhang L, et al. Bacterial efflux pump inhibitors reduce antibiotic resistance. Pharmaceutics. 2024;16:170 https://doi.org/10.3390/ pharmaceutics16020170. 14. Bradbury JD, et al. Development of an inhibitor of the mutagenic SOS response that suppresses the evolution of quinolone antibiotic resistance. Chem Sci. 2024;15:9620–9. https://doi.org/10. 1039/d4sc00995a. 15. Nautiyal A, Patil KN, Muniyappa K. Suramin is a potent and selective inhibitor of Mycobacterium tuberculosis RecA protein and the SOS response: RecA as a potential target for antibacterial drug discovery. J Antimicrob Chemother. 2014;69:1834–43. https://doi.org/10.1093/jac/dku080. 16. Bunnell BE, et al. Zinc blocks SOS-induced antibiotic resistance via inhibition of RecA in Escherichia coli. PLoS One. 2017;12:e0178303 https://doi.org/10.1371/journal.pone.0178303. 17. Crane JK, Alvarado CL, Sutton MD. Role of the SOS response in the generation of antibiotic resistance in vivo. Antimicrob Agents Chemother. 2021;65:e00013–21. https://doi.org/10.1128/aac. 00013-21. 18. Ghosh S, Orman MA. Exploring the links between SOS response, mutagenesis, and resistance during the recovery period. Antimicrob Agents Chemother. 2024;68:e01462–23. https://doi.org/ 10.1128/aac.01462-23. 19. Memar MY, et al. The central role of the SOS DNA repair system in antibiotics resistance: A new target for a new infectious treatment strategy. Life Sci. 2020;262:e118562 https://doi.org/10. 1016/j.lfs.2020.118562. 20. Ye J, et al. The expression regulation of recA gene and bacterial class 2 integron-associated genes induced by antibiotics. Front Microbiol. 2025;16:e632813 https://doi.org/10.3389/fmicb.2025. 1632813. 21. Podlesek Z, Žgur Bertok D. The DNA damage inducible SOS response is a key player in the generation of bacterial persister cells and population wide tolerance. Front Microbiol. 2020;11:e1785 https://doi.org/10.3389/fmicb.2020.01785. 22. Janion C. Inducible SOS response system of DNA repair and mutagenesis in Escherichia coli. Int J Biol Sci. 2008;4:e338 https://doi.org/10.7150/ijbs.4.338. 23. Bellio P, et al. SOS response in bacteria: Inhibitory activity of lichen secondary metabolites against Escherichia coli RecA protein. Phytomedicine. 2017;29:11–8. https://doi.org/10.1016/j. phymed.2017.04.001. 24. Recacha E, et al. Quinolone resistance reversion by targeting the SOS response. mBio. 2017;8:e00971–17. https://doi.org/10.1128/ mBio.00971-17. B. Şener, B. Gökalsın 25. Alam MK, Alhhazmi A, DeCoteau JF, Luo Y, Geyer CR. RecA inhibitors potentiate antibiotic activity and block evolution of antibiotic resistance. Cell Chem Biol. 2016;23:381–91. https://doi. org/10.1016/j.chembiol.2016.02.010. 26. Zhao Y, Wang M, Xu B. A comprehensive review on secondary metabolites and health- promoting effects of edible lichen. J Funct Foods. 2021;80:e104283 https://doi.org/10.1016/j.jff.2020. 104283. 27. Alavi M, Hamblin MR, Kennedy JF. Antimicrobial applications of lichens: secondary metabolites and green synthesis of silver nanoparticles: a review. Nano Micro Biosyst. 2022;1:15–21. https://doi.org/10.1016/j.nmb.2022.01.003. 28. Maciąg-Dorszyńska M, Węgrzyn G, Guzow-Krzemińska B. Antibacterial activity of lichen secondary metabolite usnic acid is primarily caused by inhibition of RNA and DNA synthesis. FEMS Microbiol Lett. 2014;353:57–62. https://doi.org/10.1111/15746968.12404. 29. Odimegwu DC, Ejikeugwu C, Esimone CO. Lichen secondary metabolites as possible antiviral agents. In: Ranković B, editor. Lichen Secondary Metabolites. Cham: Springe; 2015. pp. 165–77. https://doi.org/10.1007/978-3-319-13374-4_7 30. Furmanek Ł, Czarnota P, Seaward MRD. Antifungal activity of lichen compounds against dermatophytes: a review. J Appl Microbiol. 2019;127:308–25. https://doi.org/10.1111/jam.14285. 31. Dar TUH, et al. Lichens as a repository of bioactive compounds: an open window for green therapy against diverse cancers. Semin Cancer Biol. 2022;86:1120–37. https://doi.org/10.1016/j.semca ncer.2022.02.018. 32. Gökalsın B, Sesal NC. Lichen secondary metabolite evernic acid as potential quorum sensing inhibitor against Pseudomonas aeruginosa. World J Microbiol Biotechnol. 2016;32:1–7. https://doi. org/10.1007/s11274-016-2105-5. 33. Taslimi P, Gulçin İ. Antioxidant and anticholinergic properties of olivetol. J Food Biochem. 2018;42:e12516 https://doi.org/10.1111/jfbc. 12516. 34. Oettl SK, et al. Imbricaric acid and perlatolic acid: Multi-targeting anti-inflammatory depsides from Cetrelia monachorum. PLoS One. 2013;8:e76929 https://doi.org/10.1371/journal.pone.0076929. 35. Yılmaz M, Tay T, Kıvanç M, Türk H, Türk AÖ. The antimicrobial activity of extracts of the lichen Hypogymnia tubulosa and its 3-hydroxyphysodic acid constituent. Z Naturforsch. 2005;6:35–8. https://doi.org/10.1515/znc-2005-1-207. 36. Kohanski MA, Dwyer DJ, Collins JJ. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol. 2010;8:423–35. https://doi.org/10.1038/nrmicro2333. 37. Ghodke H, et al. Spatial and temporal organization of RecA in the Escherichia coli DNA-damage response. eLife. 2019;8:e42761. https://doi.org/10.7554/eLife.42761. 38. Revitt-Mills SA, et al. Defects in DNA double-strand break repair resensitize antibiotic- resistant Escherichia coli to multiple bactericidal antibiotics. MicrobiologyOpen. 2022;11:e1316. https:// doi.org/10.1002/mbo3.1316. 39. Henrikus SS, et al. Single-molecule live-cell imaging reveals RecB-dependent function of DNA polymerase IV in double strand break repair. Nucleic Acids Res. 2020;48:8490–508. https://doi. org/10.1093/nar/gkaa597. 40. Gökalsın B, Aksoydan B, Erman B, Sesal NC. Reducing virulence and biofilm of Pseudomonas aeruginosa by potential quorum sensing inhibitor carotenoid: zeaxanthin. Microb Ecol. 2017;74:466–73. https://doi.org/10.1007/s00248-017-0949-3. 41. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pairwise correlations. Biotechnol Lett. 2004;26:509–15. https://doi. org/10.1023/b:bile.0000019559.84305.47. Inhibition of the SOS response by olivetol improves the efficacy of DNA-damaging antibiotics in. . . 42. Lanyon-Hogg T. Targeting the bacterial SOS response for new antimicrobial agents: drug targets, molecular mechanisms and inhibitors. Future Med Chem. 2021;13:143–55. https://doi.org/10. 4155/fmc-2020-0310. 43. Mo CY, et al. Systematically altering bacterial SOS activity under stress reveals therapeutic strategies for potentiating antibiotics. mSphere. 2016;1:e00163–16. https://doi.org/10.1128/mSphere. 00163-16. 44. Cory MB, et al. The LexA–RecA* structure reveals a cryptic lockand-key mechanism for SOS activation. Nat Struct Mol Biol. 2024;31:1522–31. https://doi.org/10.1038/s41594-024-01317-3. 45. Cordell SC, Robinson EJ, Löwe J. Crystal structure of the SOS cell division inhibitor SulA and in complex with FtsZ. Proc Natl Acad Sci USA. 2003;100:7889–94. https://doi.org/10.1073/pnas. 1330742100. 46. Brent R, Ptashne M. The lexA gene product represses its own promoter. Proc Natl Acad Sci USA. 1980;77:1932–6. https://doi. org/10.1073/pnas.77.4.1932. 553 47. Yakimov A, Bakhlanova I, Baitin D. Targeting evolution of antibiotic resistance by SOS response inhibition. Comput Struct Biotechnol J. 2021;19:777–83. https://doi.org/10.1016/j.csbj.2021.01.003. 48. Erental A, Sharon I, Engelberg-Kulka H. Two programmed cell death systems in Escherichia coli: an apoptotic-like death is inhibited by the mazEF-mediated death pathway. PLoS Biol. 2012;10:e1001281. https://doi.org/10.1371/journal.pbio.1001281. 49. Feliciello I, et al. Regulation of ssb Gene Expression in Escherichia coli. Int J Mol Sci. 2022;23:e10917. https://doi.org/10.3390/ ijms231810917. 50. da Silva Ribeiro ÁC, et al. Exposure to sub-inhibitory ciprofloxacin and nitrofurantoin concentrations increases recA gene expression in uropathogenic Escherichia coli: The role of RecA protein as a drug target. Eur J Pharma Sci. 2020;146:e105268.